MITF targets are up-regulated by MAPK-pathway inhibitors [137], and enforced expression of MITF in BRAFV600E melanoma cells promotes resistance towards inhibitors of RAF, MEK and ERK [for review 134]. Here, MAP2K7 is linked to melanoma.